Full-Time

Director of Engineering Embedded Software

Full Spectrum

Full Spectrum

51-200 employees

Medical device software development and testing

Compensation Overview

$165k - $225k/yr

+ Bonus

Westborough, MA, USA

Hybrid

Hybrid role; on-site in Westborough, Massachusetts expected.

Bachelor's, Master's

Category
Engineering Management (1)
Required Skills
Agile
Software Testing
Git
C/C++
DevOps
Linux/Unix

Get referred to Full Spectrum

See people who can refer or advise you

Requirements
  • 10+ years recent experience with modern embedded C++
  • Experience developing medical devices or other safety critical systems
  • Strong hands-on experience with embedded development on Linux, Windows, an RTOS, or bare metal
  • Strong experience with modern SDLC processes (unit testing, static analysis, CI/CD)
  • Strong familiarity with modern software development tools (Git, SVN, or other industry-standard source control) and SDLC processes
  • Experience using Agile techniques, including task / issue management
  • Demonstrated commitment to high quality
  • Strong oral and written communication skills
  • Highly motivated, self-disciplined, independent and results oriented
Responsibilities
  • Collaborate directly with clients to define and execute the technical strategy for embedded software development projects, ensuring alignment with company goals and client needs.
  • Provide hands-on technical guidance and architectural oversight for complex embedded software projects.
  • Stay abreast of industry trends, emerging technologies, and best practices in embedded systems, medical device development, and cybersecurity.
  • Drive innovation and continuous improvement in our software development processes and toolchains.
  • Oversee the end-to-end software development lifecycle for multiple projects, from requirements definition through verification and validation.
  • Collaborate with Technical Project Managers to ensure projects are delivered on time and within scope.
  • Ensure all embedded software development activities comply with medical device regulations and standards (e.g., IEC 62304, ISO 13485), including software requirements specifications, software architecture and design documents, and risk management and cybersecurity plans and assessments (including FMEAs).
  • Collaborate with Business Development staff to introduce prospective customers to the company’s capabilities and expertise and to develop technical proposals for new client work.
  • Lead, mentor, and grow a high-performing team of embedded software engineers.
  • Conduct performance reviews, provide career development opportunities, and foster a culture of excellence, collaboration, and accountability.
  • Recruit top talent and build a robust team to meet the demands of our growing business.
Desired Qualifications
  • Bachelor’s or Master’s degree in Software Engineering or related field
  • 10+ years of experience in embedded software development, with at least 3 years in a leadership role
  • Extensive experience with full product development lifecycle for medical devices, from concept to commercialization
  • Proven expertise in C/C++ programming for embedded systems
  • Deep understanding of real-time operating systems (RTOS) and embedded Linux
  • Demonstrated experience with hardware-software integration, including low-level driver development and debugging
  • In-depth knowledge of medical device regulations and standards, especially IEC 62304
  • Experience with cybersecurity for embedded systems
  • Excellent communication, interpersonal, and client-facing skills
  • Proven ability to manage multiple projects in a fast-paced, services-based environment

Full Spectrum Software (FSS) provides end-to-end software development and testing services for highly regulated industries, including Medical Devices, Life Sciences, Digital Health, Robotics, IoT, and AI. It builds and tests software and systems, guiding products from concept to deployment, with a focus on thorough documentation, regulatory alignment, and project ownership from start to finish. The company leverages ISO 13485:2016, FDA-related processes, and a track record of delivering more than 450 commercial products on time and within budget, making it a trusted partner for clients requiring compliant, dependable software. Its differentiators include deep expertise in regulated domains, proven delivery reliability, and a history of pioneering AI solutions and IoT connectivity. The overarching goal is to help customers bring safe, compliant digital health and device software to market by providing complete lifecycle software development and validation services.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Southborough, Massachusetts

Founded

1996

Get referred to Full Spectrum

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 growth hit 50 percent, with 12 new clients added.
  • The Westborough move expands hiring capacity and supports continued 2026 expansion.
  • July 9, 2025 cybersecurity services broaden the stack as device-security demand intensifies.

What critics are saying

  • Customer concentration risk persists; one large account can dominate utilization and cash flow.
  • Robotics and medtech hiring exposes revenue to certification delays and program cancellations.
  • A failed quality incident on a regulated program would crater trust and trigger FDA scrutiny.

What makes Full Spectrum unique

  • ISO 13485-certified since 2009 anchors Full Spectrum's regulated medical-device credibility.
  • Full Spectrum spans medical devices, digital health, robotics, IoT, and AI under one roof.
  • The firm owns end-to-end delivery, from concept through testing and FDA submission support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-3%

2 year growth

-3%
HealthTech HotSpot
Jul 29th, 2026
Full Spectrum achieves 50 percent growth, expands client portfolio, and moves to new headquarters.

Full Spectrum achieves 50 percent growth, expands client portfolio, and moves to new headquarters. WESTBOROUGH, Mass.-(BUSINESS WIRE)-#healthcare - Full Spectrum, a rapidly growing product development and consulting company specializing in the medical device, digital health, and life science industries, today announces significant growth and expansion at the mid-year mark, with the organization growing by 50 percent compared to this time last year, the addition of 12 new clients, and the strengthening of existing customer relationships. To support its continued momentum, the company has moved to larger office space to accommodate its growing team and future expansion. Full Spectrum experienced strong demand for its services between June 2025 and June 2026, successfully onboarding a dozen new clients in the neurology, medical imaging, cardiology, and drug delivery spaces. Over this time, the company also expanded the scope of work and strategic partnerships with many long-standing customers. "I've been reflecting on the amazing journey Full Spectrum has been on over the last 12 months," said Adam Hesse, Full Spectrum CEO. "But even more important than our growth as an organization is our impact on health and well-being worldwide by helping our clients deliver life changing therapies to patients who need them. This is our mission as an organization, and the success over the last year has allowed us to realize that mission." Full Spectrum's new office space, located at 1500 W Park Drive, Suite 200, Westborough, Mass., 01581, provides expanded capacity for collaboration, innovation, and future hiring initiatives. The move represents another milestone in the company's long-term growth strategy and commitment to serving clients at the highest level. About Full Spectrum Full Spectrum helps MedTech innovators bring complex products to market faster and with greater confidence. Through its Full Spectrum Assured commitment, the company combines deep expertise in software, systems engineering, product development, and technology consulting with clear communication, disciplined execution, and accountability for outcomes. For more than 40 years, Full Spectrum has partnered with medical device, digital health, and life sciences companies to reduce risk, accelerate innovation, and deliver solutions engineered for real-world performance. Learn more at https://fullspectrumsoftware.com/.

HIT Consultant
Apr 15th, 2025
The Ai Hype Cycle In Medtech: Navigating The Trough Of Disillusionment

Adam Hesse, CEO, at Full SpectrumThe emerging technologies hype cycle had multiple AI applications at the peak of inflated expectations in 2023 and were just beginning the ride down to the Trough of Disillusionment in 20241 2. For years, it’s been said that “the use of data and algorithms is going to transform healthcare.” While true to a degree, we see that MedTech companies that invest in trends like artificial neural networks, analytics, big data analytics, and now AI, often struggle to yield a significant return on investment. These technologies are undoubtedly valuable, but why do so many organizations fail to capitalize? RD dollars are precious and represent the fuel for your organization’s future growth. AI without a clear business model and an understanding of the implementation and management costs is likely to be an expensive program that fails to live up to expectations. Assessing the full impact of any new technology is an imprecise exercise, and delaying participation in the next “gold rush” could leave your business lagging behind competitors. However, spending potentially millions of dollars without a return is a larger risk. A few common mistake patterns include:New Technology Indulgence – Attempting to apply a new technology in too many places, missing a focused strategy.Guess and Launch – Informally evolving a proof of concept into a formal product that’s challenging to control.Lacking Data Management – In AI, data has a lifecycle, just like software code. The infrastructure to support it is required to be efficient and compliant. No Financial Model – Not having a defined connection between your AI initiative and your PL.Below are some key steps to help maximize the impact of limited RD funds, seize market opportunities, and maintain organizational focus, ultimately increasing the chances of AI successfully transforming your business.Focus on a ProblemBegin with the unresolved problems your customers already face—many of which you likely know

Startups Latam
Dec 5th, 2024
Colektia secures $9M for digital collections

Chilean digital debt collection startup Colektia secured $9 million in funding led by Mouro Capital, with participation from Endeavor’s Forward Fund, Full Spectrum Capital, Anteris, and angel investors. Founded in 2018, Colektia aims to impact over 30 million clients by 2025 using AI and automated technologies. The company has managed over 15 million accounts and $1.6 billion in debt, achieving a CAGR of over 170% and positive net income in 2023.